United Airlines Cracks Down on Capital Spending: Will Boeing Suffer?

United Airlines Cracks Down on Capital Spending: Will Boeing Suffer?

Last month, airline giant United Continental (NYSE:UAL) unveiled a notable shift in its capital spending plans. Under newly installed CFO Andrew Levy, United is reining in capex, starting with 61 Boeing (NYSE:BA) 737s that were deferred indefinitely. Levy has signaled that more changes to United’s order book are on the horizon. This could be bad → Read More

Will 2017 Be CVS Health Corporation's Worst Year Yet?

Will 2017 Be CVS Health Corporation's Worst Year Yet?

It’s been a pretty rough year for CVS Health (NYSE:CVS). Even though the giant pharmacy services company beat earnings estimates in each of the first three quarters of 2016, shares are down around 18% due to significant problems that arose in the latter part of the year. Are those problems enough to make 2017 CVS Health’s → Read More

New Wall Street Journal ad: subscribe to us, we saw Trump's election coming

New Wall Street Journal ad: subscribe to us, we saw Trump's election coming

Many print and digital news outlets, from The New York Times to Vanity Fair, are seeking subscribers by embracing Donald Trump’s criticism of them and alluding to the potential challenges of the years ahead. The Wall Street Journal is doing it differently. In a new ad campaign, the Journal basically says: Unlike the rest of → Read More

Is It Time to Worry About Alaska Airlines' Debt?

Is It Time to Worry About Alaska Airlines' Debt?

As Alaska Air Group (NYSE:ALK) celebrated the completion of its acquisition of Virgin America last week, at least one instititution declined to laud the merger. S&P Global Ratings cut Alaska’s credit rating from BB+ to BBB-, which is the lowest rating by which Alaska can be considered investment grade. The next notch down is “junk” → Read More

Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys

Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys

You might like Gilead Sciences (NASDAQ:GILD). So do I. In particular, I like the big biotech’s dirt-cheap valuation. I like its dividend. And I really like its cash stockpile. But if those are the reasons you like Gilead, I have news: There are better stocks in each category. Here’s why you might want to forget → Read More

Obamacare 2017 enrollment hits record, despite Trump's threat to repeal

Obamacare 2017 enrollment hits record, despite Trump's threat to repeal

Burwell: Obamacare repeal would be ‘chaos’ Though President-elect Donald Trump has vowed to repeal Obamacare next month, a record number of people have signed up for coverage for 2017. Nearly 6.4 million Americans have selected Obamacare policies through the federal exchange for coverage starting Jan. 1, federal officials announced Wednesday. That’s 400,000 more than had → Read More

Trump sons removed as directors of nonprofit

Trump sons removed as directors of nonprofit

Trump’s conflicts of interest are unprecedented Donald Trump Jr. and Eric Trump are no longer listed as directors of a nonprofit that appeared to advertise a meeting with the incoming president in exchange for a $1 million donation. Paperwork removing their names from the Opening Day Foundation’s list of directors was received and processed Wednesday → Read More

Hyundai fires its U.S. CEO

Hyundai fires its U.S. CEO

A joy ride with Henry Ford III Hyundai fired the CEO of its U.S. operations Wednesday, effective immediately, following disappointing sales and the difficult launch of its luxury Genesis brand here. Dave Zuchowski had been with Hyundai since 2007 and had been head of its U.S. operations since the start of 2014. The company did → Read More

3 Catalysts for Tesla Motors, Inc.'s Vehicle Deliveries This Quarter

3 Catalysts for Tesla Motors, Inc.'s Vehicle Deliveries This Quarter

As far as deliveries go, electric-car maker Tesla Motors (NASDAQ:TSLA) crushed it last quarter. Deliveries were up 114% year over year and 72% sequentially. But despite the recent rapid growth, Tesla’s guidance for the final quarter of the year suggested management only anticipated a modest hike in unit sales. The company said it expects deliveries → Read More

Twitter's Brain Drain Seems Unstoppable

Twitter's Brain Drain Seems Unstoppable

Another day, another executive departure. This time around, we’re talking about Twitter (NYSE:TWTR) CTO Adam Messinger leaving the struggling social media company. Messinger tweeted out a brief farewell tweet last night announcing his departure: After 5 years I’ve decided to leave Twitter and take some time off. Grateful to @jack for the opportunity and to → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.